Influence of high-fat feeding, diet-induced obesity, and hyperamylinemia on the sensitivity to acute amylin

Physiology and Behavior

Volumn 104, Issue 1, 2011, Pages 20-28

  Boyle, Christina N ^a   Rossier, Mélanie M ^a   Lutz, Thomas A ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Adiposity; Amylin; Food restriction; High fat; Hyperamylinemia; Satiation

Indexed keywords

AMYLIN; INSULIN; LEPTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANOREXIA; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; FOOD INTAKE; HORMONE BLOOD LEVEL; HORMONE SENSITIVITY; HYPERAMYLINEMIA; LIPID DIET; NONHUMAN; OBESITY; PRIORITY JOURNAL; RAT;

ANIMALS; BODY COMPOSITION; BODY WEIGHT; DIETARY FATS; EATING; FOOD DEPRIVATION; INFUSION PUMPS, IMPLANTABLE; INSULIN; ISLET AMYLOID POLYPEPTIDE; LEPTIN; OBESITY; RATS; RATS, SPRAGUE-DAWLEY;

EID: 79957636761     PISSN: 00319384     EISSN: 1873507X     Source Type: Journal    
DOI: 10.1016/j.physbeh.2011.04.044     Document Type: Article

References (46)

1. Maffei M., Halaas J., Ravussin E., Pratley R.E., Lee G.H., Zhang Y., et al. Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med 1995, 1:1155-1161.
2. Bagdade J.D., Bierman E.L., Porte D. The significance of basal insulin levels in the evaluation of the insulin response to glucose in diabetic and nondiabetic subjects. J Clin Invest 1967, 46:1549-1557.
3. Levin B.E., Dunn-Meynell A.A., Banks W.A. Obesity-prone rats have normal blood-brain barrier transport but defective central leptin signaling before obesity onset. Am J Physiol Regul Integr Comp Physiol 2004, 286:R143-R150.
4. Clegg D.J., Benoit S.C., Reed J.A., Woods S.C., Dunn-Meynell A., Levin B.E. Reduced anorexic effects of insulin in obesity-prone rats fed a moderate-fat diet. Am J Physiol Regul Integr Comp Physiol 2005, 288:R981-R986.
5. Banks W.A. Blood-brain barrier as a regulatory interface. Forum Nutr 2010, 63:102-110.
6. Munzberg H. Leptin-signaling pathways and leptin resistance. Forum Nutr 2010, 63:123-132.
7. Knight Z.A., Hannan K.S., Greenberg M.L., Friedman J.M. Hyperleptinemia is required for the development of leptin resistance. PLoS One 2010, 5:e11376.
8. Covasa M., Ritter R.C. Rats maintained on high-fat diets exhibit reduced satiety in response to CCK and bombesin. Peptides 1998, 19:1407-1415.
9. Primeaux S.D., Barnes M.J., Braymer H.D., Bray G.A. Sensitivity to the satiating effects of exendin 4 is decreased in obesity-prone Osborne-Mendel rats compared to obesity-resistant S5B/Pl rats. Int J Obes (Lond) 2010, 34:1427-1433.
10. Pieber T.R., Roitelman J., Lee Y., Luskey K.L., Stein D.T. Direct plasma radioimmunoassay for rat amylin-(1-37): concentrations with acquired and genetic obesity. Am J Physiol 1994, 267:E156-E164.
11. Leckstrom A., Lundquist I., Ma Z., Westermark P. Islet amyloid polypeptide and insulin relationship in a longitudinal study of the genetically obese (ob/ob) mouse. Pancreas 1999, 18:266-273.
12. Enoki S., Mitsukawa T., Takemura J., Nakazato M., Aburaya J., Toshimori H., et al. Plasma islet amyloid polypeptide levels in obesity, impaired glucose tolerance and non-insulin-dependent diabetes mellitus. Diabetes Res Clin Pract 1992, 15:97-102.
13. Koda J.E., Fineman M., Rink T.J., Dailey G.E., Muchmore D.B., Linarelli L.G. Amylin concentrations and glucose control. Lancet 1992, 339:1179-1180.
14. Lutz T.A., Geary N., Szabady M.M., Del Prete E., Scharrer E. Amylin decreases meal size in rats. Physiol Behav 1995, 58:1197-1202.
15. Rushing P.A., Hagan M.M., Seeley R.J., Lutz T.A., D'Alessio D.A., Air E.L., et al. Inhibition of central amylin signaling increases food intake and body adiposity in rats. Endocrinology 2001, 142:5035.
16. Mack C., Wilson J., Athanacio J., Reynolds J., Laugero K., Guss S., et al. Pharmacological actions of the peptide hormone amylin in the long-term regulation of food intake, food preference, and body weight. Am J Physiol Regul Integr Comp Physiol 2007, 293:R1855-R1863.
17. Eiden S., Daniel C., Steinbrueck A., Schmidt I., Simon E. Salmon calcitonin - a potent inhibitor of food intake in states of impaired leptin signalling in laboratory rodents. J Physiol 2002, 541:1041-1048.
18. Young A. Inhibition of gastric emptying. Adv Pharmacol 2005, 52:99-121.
19. Buse J.B., Weyer C., Maggs D.G. Amylin Replacement With Pramlintide in Type 1 and Type 2 Diabetes: A Physiological Approach to Overcome Barriers With Insulin Therapy. Clin. Diabetes 2002, 20:137-144.
20. Hillebrand J.J., Langhans W., Geary N. Validation of Computed Tomographic Estimates of Intra-abdominal and Subcutaneous Adipose Tissue in Rats and Mice. Obesity (Silver Spring) 2010, 18:848-853.
21. Gloy V.L., Lutz T.A., Langhans W., Geary N., Hillebrand J.J. Basal plasma levels of insulin, leptin, ghrelin, and amylin do not signal adiposity in rats recovering from forced overweight. Endocrinology 2010, 151:4280-4288.
22. Trevaskis J.L., Coffey T., Cole R., Lei C., Wittmer C., Walsh B., et al. Amylin-mediated restoration of leptin responsiveness in diet-induced obesity: magnitude and mechanisms. Endocrinology 2008, 149:5679-5687.
23. Brownlow B.S., Park C.R., Schwartz R.S., Woods S.C. Effect of meal pattern during food restriction on body weight loss and recovery after refeeding. Physiol Behav 1993, 53:421-424.
24. Li Y., Bujo H., Takahashi K., Shibasaki M., Zhu Y., Yoshida Y., et al. Visceral fat: higher responsiveness of fat mass and gene expression to calorie restriction than subcutaneous fat. Exp Biol Med (Maywood) 2003, 228:1118-1123.
25. Duarte F.O., Sene-Fiorese M., Manzoni M.S., de Freitas L.F., Cheik N.C., Garcia de Oliveira Duarte A.C., et al. Caloric restriction and refeeding promoted different metabolic effects in fat depots and impaired dyslipidemic profile in rats. Nutrition 2008, 24:177-186.
26. Clegg D.J., Gotoh K., Kemp C., Wortman M.D., Benoit S.C., Brown L.M., et al. Consumption of a high-fat diet induces central insulin resistance independent of adiposity. Physiol Behav 2011, 103:10-16.
27. Banks W.A., Coon A.B., Robinson S.M., Moinuddin A., Shultz J.M., Nakaoke R., et al. Triglycerides induce leptin resistance at the blood-brain barrier. Diabetes 2004, 53:1253-1260.
28. Boyle C.N., Lutz T.A. Amylinergic control of food intake in lean and obese rodents. Physiol Behav 2011.
29. Seeley R.J., Matson C.A., Chavez M., Woods S.C., Dallman M.F., Schwartz M.W. Behavioral, endocrine, and hypothalamic responses to involuntary overfeeding. Am J Physiol 1996, 271:R819-R823.
30. Rushing P.A., Lutz T.A., Seeley R.J., Woods S.C. Amylin and insulin interact to reduce food intake in rats. Horm Metab Res 2000, 32:62-65.
31. Hansen T.K., Dall R., Hosoda H., Kojima M., Kangawa K., Christiansen J.S., et al. Weight loss increases circulating levels of ghrelin in human obesity. Clin Endocrinol (Oxf) 2002, 56:203-206.
32. Cui C., Ohnuma H., Daimon M., Susa S., Yamaguchi H., Kameda W., et al. Ghrelin infused into the portal vein inhibits glucose-stimulated insulin secretion in Wistar rats. Peptides 2008, 29:1241-1246.
33. Roth J.D., Roland B.L., Cole R.L., Trevaskis J.L., Weyer C., Koda J.E., et al. Leptin responsiveness restored by amylin agonism in diet-induced obesity: evidence from nonclinical and clinical studies. Proc Natl Acad Sci U S A 2008, 105:7257-7262.
34. Merino B., Cano V., Guzman R., Somoza B., Ruiz-Gayo M. Leptin-mediated hypothalamic pathway of cholecystokinin (CCK-8) to regulate body weight in free-feeding rats. Endocrinology 2008, 149:1994-2000.
35. Levin B.E., Dunn-Meynell A.A., Balkan B., Keesey R.E. Selective breeding for diet-induced obesity and resistance in Sprague-Dawley rats. Am J Physiol 1997, 273:R725-R730.
36. Levin B.E., Dunn-Meynell A.A. Reduced central leptin sensitivity in rats with diet-induced obesity. Am J Physiol Regul Integr Comp Physiol 2002, 283:R941-R948.
37. Lutz T.A., Senn M., Althaus J., Del Prete E., Ehrensperger F., Scharrer E. Lesion of the area postrema/nucleus of the solitary tract (AP/NTS) attenuates the anorectic effects of amylin and calcitonin gene-related peptide (CGRP) in rats. Peptides 1998, 19:309-317.
38. Riediger T., Schmid H.A., Lutz T., Simon E. Amylin potently activates AP neurons possibly via formation of the excitatory second messenger cGMP. Am J Physiol Regul Integr Comp Physiol 2001, 281:R1833-R1843.
39. Riediger T., Zuend D., Becskei C., Lutz T.A. The anorectic hormone amylin contributes to feeding-related changes of neuronal activity in key structures of the gut-brain axis. Am J Physiol Regul Integr Comp Physiol 2004, 286:R114-R122.
40. Olsson M., Herrington M.K., Reidelberger R.D., Permert J., Arnelo U. Comparison of the effects of chronic central administration and chronic peripheral administration of islet amyloid polypeptide on food intake and meal pattern in the rat. Peptides 2007, 28:1416-1423.
41. Rushing P.A., Hagan M.M., Seeley R.J., Lutz T.A., Woods S.C. Amylin: a novel action in the brain to reduce body weight. Endocrinology 2000, 141:850-853.
42. Arnelo U., Permert J., Adrian T.E., Larsson J., Westermark P., Reidelberger R.D. Chronic infusion of islet amyloid polypeptide causes anorexia in rats. Am J Physiol 1996, 271:R1654-R1659.
43. Wielinga P.Y., Lowenstein C., Muff S., Munz M., Woods S.C., Lutz T.A. Central amylin acts as an adiposity signal to control body weight and energy expenditure. Physiol Behav 2010, 101:45-52.
44. Wang F., Adrian T.E., Westermark G.T., Ding X., Gasslander T., Permert J. Islet amyloid polypeptide tonally inhibits beta-, alpha-, and delta-cell secretion in isolated rat pancreatic islets. Am J Physiol 1999, 276:E19-E24.
45. Salas M., Silvestre R.A., Garcia-Hermida O., Fontela T., Rodriguez-Gallardo J., Marco J. Inhibitory effect of amylin (islet amyloid polypeptide) on insulin response to non-glucose stimuli. Study in perfused rat pancreas. Diabete Metab 1995, 21:269-273.
46. Gebre-Medhin S., Mulder H., Pekny M., Westermark G., Tornell J., Westermark P., et al. Increased insulin secretion and glucose tolerance in mice lacking islet amyloid polypeptide (amylin). Biochem Biophys Res Commun 1998, 250:271-277.